Synthego, the genome engineering company, today announced it received the Technology Award at the European Laboratory Research & Innovation Group’s (ELRIG) CRISPR in Drug Discovery 2020 meeting in Cambridge, United Kingdom. Selected from among 19 nominees as the 2020 winner by the international team of drug discovery experts, Synthego’s Arrayed CRISPR Screening Libraries were recognized as an innovation in increasing efficiency in preclinical stages of drug discovery.
"As CRISPR screening in cell lines becomes more routine, the next frontier is to implement these approaches in more complex model systems, such as primary cells,” said Jonathan Weissman, professor of Biology at Massachusetts Institute of Technology. “Synthego's Arrayed CRISPR Screening Libraries and sgRNA kits have been transformative for our high-throughput screening efforts to answer central questions in innate immune recognition, antigen presentation, and T-cell polarization, among others, in primary human dendritic cells."
By using an arrayed CRISPR screen, researchers investigate how human ...
